Magnesium Deficiency: Forms, Bioavailability, and Health Effects

Half the Country Is Running Low

National Health and Nutrition Examination Survey (NHANES) data consistently shows that approximately 48% of Americans consume less magnesium than the Estimated Average Requirement — 350 mg/day for adult men, 265 mg/day for adult women. Suboptimal magnesium intake does not produce the acute deficiency symptoms of hypomagnesemia (serum magnesium <0.75 mmol/L), which are rare. It produces something subtler: impaired enzyme function across over 300 magnesium-dependent reactions, including ATP synthesis, DNA repair, and neuromuscular transmission. The gap between "not deficient" and "optimally supplied" is where most of the population lives.

Why Serum Magnesium Lies

The standard clinical test — serum magnesium — reflects only 0.3% of total body magnesium. The rest resides in bone (60%), muscle (27%), and intracellular compartments (12%). Serum magnesium is tightly regulated; it stays normal until body stores are severely depleted. Functional magnesium insufficiency — enough to impair cellular processes — can exist with a perfectly normal serum level. Red blood cell (RBC) magnesium is a better proxy but rarely ordered. This diagnostic blind spot means magnesium insufficiency is systematically undercounted in clinical practice.

Bioavailability by Form: A Comparison That Actually Matters

The supplement market sells at least a dozen magnesium compounds. Bioavailability — the fraction absorbed and available for physiological use — varies dramatically.

Magnesium oxide dominates pharmacy shelves because it is cheap and has high elemental magnesium content by weight. Its actual absorption is low. Glycinate and citrate deliver far more usable magnesium per dose and are preferred by most sports medicine and clinical nutrition practitioners.

Sleep and REM Architecture

Magnesium acts as a natural NMDA (N-methyl-D-aspartate) receptor antagonist and GABA-A receptor agonist — two mechanisms directly relevant to sleep initiation and maintenance. A 2012 randomized controlled trial by Abbasi et al. in elderly subjects (Journal of Research in Medical Sciences) found 500 mg/day of magnesium oxide for 8 weeks significantly increased sleep time, sleep efficiency, serum melatonin, and serum renin while reducing sleep onset latency and serum cortisol. Crucially, slow-wave sleep (SWS) and REM duration increased — not just total sleep time. Magnesium's role in regulating NMDA receptor activity may explain its effect on sleep architecture, as NMDA overactivity disrupts sleep cycling.

• Magnesium glycinate is preferred over oxide for sleep supplementation due to superior absorption and negligible laxative effect at typical doses (200–400 mg elemental Mg).
• Taking magnesium 30–60 minutes before sleep aligns with its mechanism; it does not act as a sedative but as an excitability modulator.
• Low dietary magnesium independently predicts worse sleep quality in observational data (Black et al., Journal of Sleep Research 2018).

Insulin Sensitivity and Metabolic Function

Magnesium is a required cofactor for tyrosine kinase activity of the insulin receptor. Low intracellular magnesium impairs insulin receptor signaling and reduces GLUT4 translocation — the transporter that moves glucose into muscle cells. A 2011 meta-analysis (Mathers et al.) of 9 prospective cohort studies found each 100 mg/day increase in dietary magnesium intake associated with a 15% lower risk of type 2 diabetes. A 2016 meta-analysis (Veronese et al., European Journal of Clinical Nutrition) of 18 RCTs found magnesium supplementation significantly improved fasting blood glucose and HOMA-IR (insulin resistance index) in people with low baseline magnesium levels. The effect disappears in magnesium-sufficient individuals, suggesting the intervention restores function rather than providing pharmacological benefit.

Migraine Prevention

Magnesium deficiency is documented in migraine sufferers. Ionized magnesium is low in brain cortex during migraine attacks, possibly because cortical spreading depression — the neurological phenomenon underlying aura — massively depletes magnesium. The American Migraine Foundation considers magnesium one of the few evidence-based nutraceutical preventives. A 2012 randomized trial (Peikert et al.) found 600 mg magnesium (as magnesium dicitrate) reduced attack frequency by 41.6% versus 15.8% in placebo — a statistically significant result. Several neurology guidelines now list magnesium as a first-line preventive option for migraine with aura, typically at 400–600 mg/day.

• The RDA for magnesium is 420 mg/day for adult men and 320 mg/day for adult women (National Institutes of Health, Office of Dietary Supplements).
• Dietary sources highest in magnesium include pumpkin seeds (156 mg/oz), almonds, dark chocolate, black beans, and leafy greens.
• High-dose supplementation above 350 mg from supplements alone can cause osmotic diarrhea; the tolerable upper intake level applies only to supplemental magnesium, not food sources.

This article is for informational purposes only. Consult a qualified healthcare professional.